Stevanato Group S.p.A. (STVN) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Stevanato Group S.p.A. (STVN:NYSE), powered by AI.

Current Price
$16.51
P/E Ratio
32.2
Market Cap
4.5B
Sector
Healthcare
What is the Stevanato Group S.p.A. stock price forecast?

Stevanato Group S.p.A. is currently trading at $16.51. View real-time AI analysis on Alpha Lenz.

What is Stevanato Group S.p.A. insider trading activity?

View the latest insider trading data for Stevanato Group S.p.A. on Alpha Lenz.

What is Stevanato Group S.p.A.'s P/E ratio?

Stevanato Group S.p.A.'s P/E ratio is 32.2.

Stevanato Group S.p.A.

NYSE · STVN
$16.51-0.12(-0.72%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Stevanato Group S.p.A.'s future dividend policy...
Alpha Chat Insight

Stevanato Group S.p.A. trades at a P/E of 32.2 (premium valuation) with solid ROE of 9.7%.

Ask for details

Company Overview

Stevanato Group S.p.A. is a leading Italian manufacturer specializing in medical equipment, supplies, and distribution, with a strong global presence in the biopharmaceutical and diagnostic solutions sectors. The company is recognized for its extensive portfolio, which includes glass primary packaging and integrated solutions for the containment and delivery of injectable drugs, as well as engineering systems for pharmaceutical manufacturing. Stevanato Group’s operations play a critical role in the healthcare supply chain, supporting the safe and efficient delivery of advanced therapies and diagnostics. Leveraging a highly collaborative approach, the company establishes long-term strategic partnerships with major pharmaceutical and biotechnology firms, contributing to high customer retention and continuous innovation. With a rapidly expanding footprint and a focus on technology-driven solutions, Stevanato Group S.p.A. is positioned as a significant player in the advancement of healthcare infrastructure and delivery across major global markets.

CEOMr. Franco Stevanato
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees5,521

Company Statistics

FY 2025

Profile

$4.51BMarket Cap
$1.19BRevenue
0.00Shares Out
5,521Employees

Margins

28.99%Gross
24.28%EBITDA
16.76%Operating
15.94%Pre-Tax
11.79%Net

Valuation

32.23P/E
3.03P/B
3.80EV/Sales
16.82EV/EBITDA
408.01P/FCF

Growth (CAGR)

6.44%Rev 3Yr
12.37%Rev 5Yr
1.09%Op Inc 3Yr
14.03%Op Inc 5Yr
-0.75%Net Inc 3Yr
12.21%Net Inc 5Yr

Returns

5.74%ROA
9.67%ROE
8.03%ROIC

Financial Health

$130.60MCash & Cash Equivalents
$926.85MNet Debt
71.14%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Stevanato Group S.p.A. (ticker: STVN) is a company listed on NYSE in the Healthcare sector (Medical Instruments & Supplies). It has approximately 5,521 employees. Market cap is $4.5B.

The current price is $16.51 with a P/E ratio of 32.23x and P/B of 3.03x.

ROE is 9.67% and operating margin is 16.76%. Annual revenue is $1.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Stevanato Group S.p.A. (STVN) Stock Forecast 2026 $16.51 — Price, Financials & Analyst Targets | Alpha Lenz